Navigation Links
AdvaMed Available for Comment on Medical Device Safety Act
Date:3/5/2009

WASHINGTON, March 5 /PRNewswire-USNewswire/ -- Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), is available today to discuss the Medical Device Safety Act to be introduced today in Congress.

If the Act were to become law, it would:

  • Chill innovation and limit patient access to cutting-edge, life-enhancing therapies; and
  • Dramatically alter the regulatory environment for certain medical devices, by creating new avenues for litigation.

To arrange an interview with Steve Ubl, please contact: Wanda Moebius at 202-434-7240.

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

    CONTACT: Wanda Moebius
    wmoebius@advamed.org
    202-434-7240


'/>"/>
SOURCE Advanced Medical Technology Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AdvaMed Response to the Medical Device Safety Act
2. Gerson Lehrman Group Partners With AdvaMed for Survey on Medical Device Industry
3. AdvaMed 2008 Sponsor Participation Increases by 52%
4. AdvaMed 2008 Opens Showcasing Latest Medical Technologies with Innovation Alley Exhibit and Next Generation Company Presentations
5. Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008
6. AdvaMed 2008 Supporting Partner Organizations Up 30% Over Last Year
7. AdvaMed Supports Key Changes to Disclosure Legislation
8. AdvaMed Supports Increased Funding for FDA
9. AdvaMed Convenes Panel to Address Health Disparities
10. AdvaMed 2007 Exceeds Attendance Expectations With More Than 1,100 Participants from 35 States and 25 Countries
11. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 30, 2016 , ... Mercy College is expanding ... The following programs will be expanding due to high demand: Master of Business Administration ... will begin this summer. , School of Business Graduate Program Chair Dr. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona Arizona's ... brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and wellness ... to the store is just one more way Shamangelic Healing supports people’s quest ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. ... of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death ... podcasted thereafter . Dr. Bernie Siegel, author of a plethora of essential ...
(Date:4/29/2016)... ... April 29, 2016 , ... A new study ... severe congenital diaphragmatic hernia have better survival rates if surgery is performed early. ... condition where the diaphragm fails to form completely, letting abdominal organs into the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... patented products, announces the Gyrociser, an exercise invention which aids in proper muscle ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery systems, ... PIONEERS 2016 conference, presented by Joseph Gunnar & ... New York . Nadav Kidron , CEO ... Presentation Details:   PIONEERS 2016, ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
Breaking Medicine Technology: